BOTAS and BP Pipelines would like to buy share in TANAP project
Turkish BOTAS pipeline company and BP Pipelined have applied to the Turkish Antimonopoly Committee to buy shares in the consortium for construction of the trans-Anadolu pipeline (TANAP), reads the information posted on the web site of the Turkish Antimonopoly Committee.
The information reads that BOTAS is going to buy 30% share in TANAP, while BP Pipelines – 12% share of Gas Corridor Closed Joint Stock Company (100% shares owned by SOCAR) in the consortium.
It is planned to put TANAP into operation in quarter 4, 2018. The project is estimated at $11.8 billion.
Until now BOTAS has not overcome all bureaucratic stages of the Turkish legislation to become a legal shareholder of the pipeline consortium, though SOCAR and BOTAS reached an agreement almost three years ago.—0—
Economics
-
As 2024 comes to a close, Azerbaijan finds itself at a crossroads—holding a prominent position in certain sectors of the global economy but still grappling with issues that hinder broader socioeconomic development. From energy exports to logistics corridors, the country has carved out a niche, yet cracks in its socioeconomic fabric are becoming harder to ignore. Let’s delve into the numbers and listen to expert opinions on Azerbaijan's global standing.
-
Azerbaijan began the new year with significant hikes in gas, electricity, water, and medication tariffs, sparking widespread concern among citizens over the financial burden on households. While officials defend the measures as necessary for economic sustainability, critics warn of challenges tied to stagnant wages and pensions.
-
As of January 1, Europe has ceased contract-based transit of Russian gas through Ukraine. Kyiv announced it would not renew agreements to traffic gas from the "aggressor nation" through its territory. The decision marks a pivotal moment in Europe’s efforts to reduce reliance on Russian energy, a dependency that supplied nearly 50% of the continent’s gas imports before the war in Ukraine.
-
Azerbaijan's Tariff Council has approved a decision to regulate the maximum wholesale and retail prices of registered medicines, with the new pricing caps coming into effect on January 2, 2025.
Leave a review